DeepIntent, a leading healthcare advertising technology company built to influence better patient health and business outcomes, announced the appointment of Amit Chaturvedi as its first Chief Operating Officer.
As DeepIntent's first Chief Operating Officer, Chaturvedi will be responsible for the overall business operations of DeepIntent and report directly to the company's founder and Chief Executive Officer, Chris Paquette. Chaturvedi's primary focus will be further integrating and scaling DeepIntent's sales, campaign management, client success & business development teams as the company executes on its plan to further define itself as the leading platform for digital advertising in healthcare.
Chaturvedi joins DeepIntent with more than two decades of operating experience in advertising technology startups and global media companies. In his last role as Executive Vice President of Revenue Operations & Product at WarnerMedia, Chaturvedi led the company's linear and digital revenue operations functions and was accountable for unifying cross-platform revenue offerings and strategy with a particular emphasis on advanced digital solutions, including CTV and audience solutions. During his tenure, revenues grew over 10x with total revenue under management exceeding $5 billion annually. Chaturvedi also previously served as COO of Taykey, a Sequoia and Softbank-backed startup that was acquired by global connected TV (CTV) leader Innovid in 2017, with prior experiences including leadership roles at aQuantive (acquired by Microsoft), IAC/InterActiveCorp, and QualityHealth (acquired by Sharecare).
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.